Pharmalogical Consideration of Infectious Disease and Agents

Pandemic, epidemic and endemic infectious diseases are united by a standard problem: how do we quickly and cost-effectively determine potential pharmacological arbitration to treat infections? The growing accessibility of parasite genome data provides the basis for developing methods to prioritize, a priori potential drug targets and analyze the pharmacological landscape of an infectious disease. Infectious diseases create totally different threats to different constituencies and thus are often treated as separate problems by governments, businesses, philanthropies and research funders: neglected diseases are treated as world health problems; emerging and pandemic diseases  as public health issues; and bio-defence as a national security issue.

    Related Conference of Pharmalogical Consideration of Infectious Disease and Agents

    November 04-05, 2022

    34th Annual Congress on Vaccine and Clinical Trials

    Toronto, Canada
    November 17-18, 2022

    2nd Global Summit on Vaccines and Immunology

    Berlin, Germany
    February 20-21, 2023

    International Conference on Vaccine Research

    Madrid, Spain
    November 06-07, 2023

    5th World Congress on Vaccine and Immunology

    Tokyo, Japan

    Pharmalogical Consideration of Infectious Disease and Agents Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in